Drug profile · INN
evans blue
EVANS BLUE
evans blue (EVANS BLUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Drug details — evans blue
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 5
- Programs
- 0
- Data quality
- 0.84
Quick answer
evans blue (EVANS BLUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related patents
-
US 12161733
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
granted -
US 10981866
Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents
granted -
US 10709790
Chemical conjugates of Evans Blue derivatives and their use in the production of long-acting therapeutics
granted -
US 10696631
Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents
granted -
US 10258701
Labeled evans blue dye derivative for in vivo serum albumin labeling
granted
Frequently asked questions
What is evans blue?
evans blue (EVANS BLUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for evans blue?
EVANS BLUE is a marketed brand name for evans blue. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of evans blue?
evans blue has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.